000 01524 a2200433 4500
005 20250518034203.0
264 0 _c20200312
008 202003s 0 0 eng d
022 _a1465-3931
024 7 _a10.1016/j.pathol.2018.11.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuthridge, Isabel
245 0 0 _aIncreasing prevalence of methicillin-resistant Staphylococcus aureus in remote Australian communities: implications for patients and clinicians.
_h[electronic resource]
260 _bPathology
_cJun 2019
300 _a428-431 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCohort Studies
650 0 4 _aCommunity-Acquired Infections
_xepidemiology
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aFemale
650 0 4 _aFloxacillin
_xpharmacology
650 0 4 _aGeography
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethicillin
_xpharmacology
650 0 4 _aMethicillin-Resistant Staphylococcus aureus
_xisolation & purification
650 0 4 _aPrevalence
650 0 4 _aQueensland
_xepidemiology
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aSpatio-Temporal Analysis
650 0 4 _aStaphylococcal Infections
_xepidemiology
700 1 _aSmith, Simon
700 1 _aHorne, Peter
700 1 _aHanson, Josh
773 0 _tPathology
_gvol. 51
_gno. 4
_gp. 428-431
856 4 0 _uhttps://doi.org/10.1016/j.pathol.2018.11.015
_zAvailable from publisher's website
999 _c29603396
_d29603396